The trial data chain is wider than the EDC screen
The EMA guideline on computerised systems and electronic data in clinical trials addresses systems and data used in clinical trials, including areas such as electronic source data, data flows, roles, and oversight. ICH E6(R3) describes Good Clinical Practice as an ethical, scientific, and quality standard intended to protect participants and support reliable trial results, while encouraging proportionate and risk-based approaches.
The practical implication is that sponsors should map the complete data lifecycle. That can include eConsent, eSource, electronic case report forms, randomisation, electronic patient-reported outcomes, wearables, imaging, laboratory systems, safety systems, data transfer, review, analysis, and archiving. Each handoff is a potential source of loss, alteration, delay, or ambiguity.
Questions for system oversight
- What is the intended use of each system and what trial decision does it support?
- Who owns the data, the configuration, the access model, the vendor relationship, and the oversight?
- How are source records, corrections, audit trails, signatures, and metadata retained?
- How are interfaces reconciled and failures detected?
- How are risk, critical data, critical processes, and monitoring activities documented?
- How are vendor changes, incidents, deviations, and data exports controlled?
- Can the sponsor retrieve and interpret the records for the required retention period?
Proportionality still requires evidence
A risk-based trial approach does not mean that low-risk data can be ignored or that a vendor declaration replaces oversight. It means the sponsor explains why the chosen controls and monitoring are appropriate to the importance of the data and the risks to participants and trial reliability. Keep the reasoning with the system and trial records.
Oversight must continue after implementation
Review system performance, data issues, access, changes, vendors, and deviations through the trial lifecycle. Include study closeout and long-term retention. The system is part of trial conduct, not just a technology purchase.
VLMS Software can help structure requirements, risk, evidence, approvals, and review for the systems in scope. Apply the applicable regional requirements and sponsor procedures to the final plan.
Connect trial-system oversight to the evidence trail
Start with the system, process, and evidence questions that matter to your team.
Talk with VLMS about your validation programme →